Clinical Trial Update: A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports the effectiveness and safety of JS1-1-01 in patients with moderate to severe depression, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• JS1-1-01

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Depression | Phase 2 | Status: COMPLETED